http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-200200823-A1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00
filingDate 2002-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-200200823-A1
titleOfInvention METHOD OF TREATMENT OF PEYRONI'S DISEASE
abstract The invention relates to medicine, in particular to urology, in particular to the development of a method of drug treatment of Peyronie's disease. The proposed method of medical treatment of Peyronie's disease. The combination contains verapamil, novocaine, lidazu and distilled water. Application of the affected area is carried out with a solution of Dimexidum. The method is characterized by high efficiency of treatment, expressed in relieving pain syndrome (including during erection), softening, in most cases, resorption of plaques and elimination of penile curvature, improving the quality of sexual intercourse, and reducing the duration of treatment and stabilizing the pathological process.
priorityDate 2002-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4914

Total number of triples: 19.